Breaking News Instant updates and real-time market news.

CANF

Can-Fite BioPharma

$3.68

-0.16 (-4.17%)

08:18
12/09/19
12/09
08:18
12/09/19
08:18

Can-Fite BioPharma completes 50% patient enrollment in Phase III psoriasis trial

Can-Fite BioPharma announced it has completed enrollment of over 50% of the 407 patients planned for its Phase III Comfort trial to evaluate its drug candidate Piclidenoson in the treatment of moderate-to-severe plaque psoriasis. The randomized, double blind study is being conducted in Europe, Israel, and Canada. The study's primary end point is the proportion of subjects who achieve a PASI score response of greater than or equal to75% vs. placebo at week 16. The secondary endpoints include non-inferiority to Otezla on weeks 16 and 32.

CANF Can-Fite BioPharma
$3.68

-0.16 (-4.17%)

03/27/19
HCWC
03/27/19
NO CHANGE
Target $3
HCWC
Buy
Can-Fite selloff yesterday on trial miss unwarranted, says H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino recommends Can-Fite BioPharma shares, especially on weakness, based on expectations for positive catalysts with piclidenoson in 2019. The company yesterday announced that its Phase 2 study with namodenoson in hepatocellular carcinoma did not achieve its primary endpoint of overall survival. The analyst, however, did not have this indication in his model and thinks the stock pullback yesterday is unwarranted. He recommends Can-Fite shares based on the potential for second half of 2019 data readouts from Phase 3 studies with its lead candidate piclidenoson in rheumatoid arthritis and psoriasis to be positive. Bernardino reiterates a Buy rating on Can-Fite BioPharma with a $3 price target. The stock closed yesterday down 28%, or 36c, to 93c.
10/31/19
HCWC
10/31/19
NO CHANGE
Target $5
HCWC
Buy
Can-Fite BioPharma price target raised to $5 from $3 at H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino raised his price target for Can-Fite BioPharma to $5 from $3 saying the company's end-of-Phase 2 meeting with the FDA concluded on a positive. The meeting resulted in the FDA agreeing the company's proposed design for a pivotal Phase 3 trial to evaluate namodenoson as a treatment for advanced liver cancer would support a New Drug Application, and if positive, regulatory approval of namodenoson as first-line therapy in hepatocellular carcinoma patients whose cancer has progressed, Bernardino tells investors in a research note. The analyst believes the announcement confirms his view that namodenoson's advancement can be a long-term driver of Can-Fite shares. He views any selloff on the news as a buying opportunity and reiterates a Buy rating on the name.

TODAY'S FREE FLY STORIES

NTDOY

Nintendo

$0.00

(0.00%)

12:51
01/22/20
01/22
12:51
01/22/20
12:51
Periodicals
Nintendo wins court case in Germany over pre-orders, Nintendo Everything says »

Nintendo has prevailed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$318.56

2.17 (0.69%)

, GOOG

Alphabet

$1,493.73

8.81 (0.59%)

12:48
01/22/20
01/22
12:48
01/22/20
12:48
Periodicals
Google researchers find multiple security flaws in Apple's Safari, FT reports »

Researchers at Google…

AAPL

Apple

$318.56

2.17 (0.69%)

GOOG

Alphabet

$1,493.73

8.81 (0.59%)

GOOGL

Alphabet Class A

$1,491.43

8.73 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 28

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

ARWR

Arrowhead

$48.17

0.54 (1.13%)

12:45
01/22/20
01/22
12:45
01/22/20
12:45
Options
Arrowhead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

MSI

Motorola Solutions

$177.26

0.29 (0.16%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
Motorola presales for foldable 'revived' Razr begin January 26, Engadget says »

After delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
French minister says France, U.S. agree on digital tax framework, AP reports »

France intends to delay…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:37
01/22/20
01/22
12:37
01/22/20
12:37
Conference/Events
Wolfe Research utilities/midstream analysts to hold luncheon meeting »

Utilities & Power…

CMCSA

Comcast

$47.44

0.13 (0.27%)

12:35
01/22/20
01/22
12:35
01/22/20
12:35
Periodicals
Olympic qualifiers moved or canceled due to coronavirus, CNN reports »

The International Olympic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DIS

Disney

$143.99

0.46 (0.32%)

12:33
01/22/20
01/22
12:33
01/22/20
12:33
Hot Stocks
Scopely acquires FoxNext Games, Cold Iron Studios from Disney »

Scopely and The Walt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

, PUGOY

Peugeot

$0.00

(0.00%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Periodicals
Fiat Chrysler CEO says PSA deal talks 'progressing really well,' Reuters says »

Fiat Chrysler (FCAU) CEO…

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

PUGOY

Peugeot

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.66

0.345 (6.49%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Conference/Events
The Executives' Club of Chicago to hold a luncheon meeting »

The Executives' Club…

SRPT

Sarepta

$121.03

-1.65 (-1.34%)

12:24
01/22/20
01/22
12:24
01/22/20
12:24
Periodicals
New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says »

New documents released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$1.96

0.04 (2.08%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Hot Stocks
Proteostasis to present data from organoid study in CF treatment »

Proteostasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNA

Moderna

$21.97

1 (4.77%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Recommendations
Moderna analyst commentary  »

Moderna mRNA technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/22/20
01/22
12:15
01/22/20
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude hit…

TWLO

Twilio

$119.62

0.47 (0.39%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
Periodicals
Breaking Periodicals news story on Twilio »

Hedgeye adds Twilio to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 24

    Feb

NFLX

Netflix

$332.00

-6.24 (-1.84%)

, IBM

IBM

$143.22

4.07 (2.92%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rebounding…

NFLX

Netflix

$332.00

-6.24 (-1.84%)

IBM

IBM

$143.22

4.07 (2.92%)

AAPL

Apple

$318.43

2.04 (0.64%)

ETN

Eaton

$97.23

2.72 (2.88%)

ABT

Abbott

$92.33

2.57 (2.86%)

NAVI

Navient

$15.02

1.16 (8.37%)

ARNC

Arconic

$28.60

-0.795 (-2.71%)

FCEL

FuelCell

$2.14

-0.735 (-25.61%)

NTRS

Northern Trust

$102.32

-6.35 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 04

    Feb

NTDOY

Nintendo

$0.00

(0.00%)

12:09
01/22/20
01/22
12:09
01/22/20
12:09
Periodicals
Judge says iLife's patent suit against Nintendo not valid, Verge says »

Federal Judge Barbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WILC

G. Willi-Food

$12.22

-0.21 (-1.69%)

12:06
01/22/20
01/22
12:06
01/22/20
12:06
Hot Stocks
G. Willi-Food CEO Michael Luboschitz to resign for personal reasons »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.41

0.77 (2.51%)

12:05
01/22/20
01/22
12:05
01/22/20
12:05
Options
Elanco Animal Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 23

    Jan

HUYA

Huya

$18.73

-1.75 (-8.54%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Huya falls -8.5% »

Huya is down -8.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMRE

Costamare

$9.01

-1.34 (-12.95%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Costamare falls -12.9% »

Costamare is down -12.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$7.28

-0.71 (-8.89%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Cango falls -9.3% »

Cango is down -9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.